3,758
Views
3
CrossRef citations to date
0
Altmetric
Review Article

INCIDENCE OF HERPES SIMPLEX VIRUS KERATITIS AND OTHER OCULAR DISEASE: GLOBAL REVIEW AND ESTIMATES

ORCID Icon, , , ORCID Icon, , , ORCID Icon & show all
Pages 353-362 | Received 23 Feb 2021, Accepted 28 Jul 2021, Published online: 08 Oct 2021

References

  • James C, Harfouche M, Welton NJ, et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull World Health Organ. 2020;98(5):315–329. doi:10.2471/BLT.19.237149.
  • Gupta R, Warren T, Wald A. Genital herpes. Lancet. 2007;370(9605):2127–2137. doi:10.1016/S0140-6736(07)61908-4.
  • Lafferty WE, Coombs RW, Benedetti J, Critchlow C, Corey L. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med. 1987;16(23):1444–1449. doi:10.1056/NEJM198706043162304.
  • Whitley RJ, Roizman B. Herpes simplex virus infections. Lancet. 2001;357(9267):1513–1518. doi:10.1016/S0140-6736(00)04638-9.
  • Ayoub HH, Chemaitelly H, Abu-Raddad LJ. Characterizing the transitioning epidemiology of herpes simplex virus type 1 in the USA: model-based predictions. BMC Med. 2019;17(1):57. doi:10.1186/s12916-019-1285-x.
  • Khadr L, Harfouche M, Omori R, et al. The epidemiology of herpes simplex virus type 1 in Asia: systematic review, meta-analyses, and meta-regressions. Clin Infect Dis. 2019;68(5):757–772. doi:10.1093/cid/ciy562.
  • Pepose JS, Keadle TL, Morrison LA. Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy. Am J Ophthalmol. 2006;141(3):547–557. doi:10.1016/j.ajo.2005.10.008.
  • Farooq AV, Shukla D. Herpes simplex epithelial and stromal keratitis: an epidemiologic update. Surv Ophthalmol. 2012;57(5):448–462. doi:10.1016/j.survophthal.2012.01.005.
  • Azher TN, Yin XT, Tajfirouz D, Huang AJ, Stuart PM. Herpes simplex keratitis: challenges in diagnosis and clinical management. Clin Ophthalmol. 2017;11:185–191. doi:10.2147/OPTH.S80475.
  • Bagga B, Kate A, Joseph J, Dave VP. Herpes simplex infection of the eye: an introduction. Community Eye Health. 2020;33:68–70.
  • Norn MS. Dendritic (herpetic) keratitis. I. Incidence–seasonal variations–recurrence rate–visual impairment–therapy. Acta Ophthalmol (Copenh). 1970;48(1):91–107. doi:10.1111/j.1755-3768.1970.tb06577.x.
  • Wilhelmus KR, Coster DJ, Donovan HC. Prognostic indicators of herpetic keratitis. Analysis of a five-year observation period after corneal ulceration. Arch Ophthalmol. 1981;99(9):1578–1582. doi:10.1001/archopht.1981.03930020452009.
  • Barron BA, Gee L, Hauck WW, et al. Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology. 1994;101(12):1871–1882. doi:10.1016/S0161-6420(13)31155-5.
  • Wilhelmus KR, Gee L, Hauck WW, et al. Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology. 1994;101(12):1883–1895. doi:10.1016/S0161-6420(94)31087-6.
  • Muthiah MN, Michaelides M, Child CS, Mitchell SM. Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK. Br J Ophthalmol. 2007;91(11):1452–1455. doi:10.1136/bjo.2007.114884.
  • Cochrane TF, Silvestri G, McDowell C, Foot B, McAvoy CE. Acute retinal necrosis in the United Kingdom: results of a prospective surveillance study. Eye. 2012;26(3):370–377. doi:10.1038/eye.2011.338.
  • Zhao XY, Meng LH, Zhang WF, Wang DY, Chen YX. Retinal detachment following acute retinal necrosis and the efficacies of different interventions: a systematic review and meta-analysis. Retina. 2021;41(5):965–978. doi:10.1097/IAE.0000000000002971.
  • Rowe AM, St Leger AJ, Jeon S, et al. Herpes keratitis. Prog Retin Eye Res. 2013;32:88–101. doi:10.1016/j.preteyeres.2012.08.002.
  • Gottlieb SL, Giersing B, Boily MC, et al. Modelling efforts needed to advance herpes simplex virus (HSV) vaccine development: key findings from the World Health Organization consultation on HSV vaccine impact modelling. Vaccine. 2019;37(50):7336–7345. doi:10.1016/j.vaccine.2017.03.074.
  • Looker KJ, Magaret AS, May MT, et al. First estimates of the global and regional incidence of neonatal herpes infection. Lancet Glob Health. e300-e309. 2017;5(3):e300–e309. doi:10.1016/S2214-109X(16)30362-X.
  • Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
  • United Nations DESA/Population Division: World Population Prospects 2017 https://population.un.org/wpp/Download/Standard/Population/ Accessed 19/ 03/2019.
  • Looker KJ, Johnston C, Welton NJ, et al. The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study. BMJ Glob Health. 2020;5(3):e001875. doi:10.1136/bmjgh-2019-001875.
  • Bremner MH. Ocular herpes simplex infections in children. Aust J Ophthalmol. 1982;10(1):27–29. doi:10.1111/j.1442-9071.1982.tb00358.x.
  • Stevens GA, Alkema L, Black RE, et al. Guidelines for Accurate and transparent health estimates reporting: the GATHER statement. Lancet. 2016;388(10062):e19–e23. doi:10.1016/S0140-6736(16)30388-9.
  • Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–2012. doi:10.1001/jama.283.15.2008.
  • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097.
  • Liesegang TJ, Melton ILJ, Daly PJ, Ilstrup DM. Epidemiology of ocular herpes simplex: incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol. 1989;107(8):1155–1159. doi:10.1001/archopht.1989.01070020221029.
  • Whitcher JP, Dawson CR, Hoshiwara I, et al. Herpes simplex keratitis in a developing country. Natural history and treatment of epithelial ulcers in Tunisia. Arch Ophthalmol. 1976;94(4):587–592. doi:10.1001/archopht.1976.03910030279006.
  • Mortensen KK, Sjolie AK. Keratitis dendritica. An epidemiological investigation. Acta Ophthalmol (Copenh). 1979;57(5):750–754. doi:10.1111/j.1755-3768.1979.tb01840.x.
  • Ribaric V. The incidence of herpetic keratitis among population. Ophthalmologica. 1976;173(1):19–22. doi:10.1159/000307814.
  • Young RC, Hodge DO, Liesegang TJ, Baratz KH. Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976-2007: the effect of oral antiviral prophylaxis. Arch Ophthalmol. 2010;128(9):1178–1183. doi:10.1001/archophthalmol.2010.187.
  • Paivonsalo-Hietanen T, Tuominen J, Vaahtoranta-Lehtonen H, Saari KM. Incidence and prevalence of different uveitis entities in Finland. Acta Ophthalmol Scand. 1997;75(1):76–81. doi:10.1111/j.1600-0420.1997.tb00255.x.
  • Tran VT, Auer C, Guex-Crosier Y, Pittet N, Herbort CP. Epidemiological characteristics of uveitis in Switzerland. Int Ophthalmol. 1994;18(5):293–298. doi:10.1007/BF00917833.
  • Stanzel TP, Diaz JD, Mather R, et al. The epidemiology of herpes simplex virus eye disease in Northern California. Ophthalmic Epidemiol. 2014;21(6):370–377. doi:10.3109/09286586.2014.966848.
  • Labetoulle M, Auquier P, Conrad H, et al. Incidence of herpes simplex virus keratitis in France. Ophthalmology. 2005;112(5):888–895. doi:10.1016/j.ophtha.2004.11.052.
  • Adhin MR, Grunberg MG, Labadie-Bracho M, Pawiroredjo J. Incidence of Alpha-Herpes virus induced ocular disease in Suriname. J Med Virol. 2012;84(12):1937–1942. doi:10.1002/jmv.23414.
  • Gomez-Mariscal M, De Arriba F, Revenga M, Gonzalez-Lopez JJ. Do season and environment have a role in the incidence of anterior uveitis attacks? Ocul Immunol Inflamm. 2020;28(5):786–790. doi:10.1080/09273948.2019.1636092.
  • Hodge WG, Margolis TP. Herpes simplex virus keratitis among patients who are positive or negative for human immunodeficiency virus: an epidemiologic study. Ophthalmology. 1997;104(1):120–124. doi:10.1016/S0161-6420(97)30351-0.
  • Claoue C, De Cock R. The spectrum of herpes simplex virus disease of the anterior segment in the 1990s. Acta Ophthalmol Scand. 1996;74(4):407–410. doi:10.1111/j.1600-0420.1996.tb00719.x.
  • Rodriguez A, Power WJ, Neves RA, Foster CS. Recurrence rate of herpetic uveitis in patients on long-term oral acyclovir. Doc Ophthalmol. 1995;90(4):331–340. doi:10.1007/BF01268121.
  • Bramer WM, Rethlefsen ML, Kleijnen J, Franco OH. Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study. Syst Rev. 2017;6(1):245. doi:10.1186/s13643-017-0644-y.
  • Steinmetz JD, Bourne RRA, Briant PS, et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. e144-e160. 2021;9(2):e144–e160. doi:10.1016/S2214-109X(20)30489-7.
  • Yorston D, Foster A. Herpetic keratitis in Tanzania: association with malaria. Br J Ophthalmol. 1992;76(10):582–585. doi:10.1136/bjo.76.10.582.
  • Schillinger JA, Xu F, Sternberg MR, et al. National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976-1994. Sex Transm Dis. 2004;31(12):753–760. doi:10.1097/01.olq.0000145852.43262.c3.
  • World Health Organization. World report on vision. https://www.who.int/publications/i/item/world-report-on-vision. 2019.
  • Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev. 2015;1:CD002898.